Evidence map›Paper›PMID 41942332›Full record

ArticleInternational neurourology journal2026

Inflammatory Signatures and Biomarkers: The Renal-Vesical Axis in Alzheimer Progression.

Yebeen Kim, Jaewoon Jung, Asifiwe Clarisse Cirunduzi, Seonghyun Yoon, Seokyoung Bang, Seung-Hoon Yang

Abstract read
In one paragraph

Article in International neurourology journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yebeen KimDepartment of Medical Biotechnology, College of Life Science and Biotechnology, Dongguk University, Seoul, Korea.
Jaewoon JungDepartment of Medical Biotechnology, College of Life Science and Biotechnology, Dongguk University, Seoul, Korea.
Asifiwe Clarisse CirunduziDepartment of Medical Biotechnology, College of Life Science and Biotechnology, Dongguk University, Seoul, Korea.
Seonghyun YoonDepartment of Medical Biotechnology, College of Life Science and Biotechnology, Dongguk University, Seoul, Korea.
Seokyoung BangDepartment of Medical Biotechnology, College of Life Science and Biotechnology, Dongguk University, Seoul, Korea.
Seung-Hoon YangDepartment of Medical Biotechnology, College of Life Science and Biotechnology, Dongguk University, Seoul, Korea.

Funding

Korea Health Industry Development Institute 2020R1F1A1076240Korea Health Industry Development Institute 2021R1C1C1009743Korea Health Industry Development Institute RS-2024-00350442Ministry of Health and Welfare RS-2024-00507256
6 · The paper itself

Abstract

Alzheimer disease (AD) has long been viewed as a disorder confined to the central nervous system. Accumulating evidence, however, indicates that systemic inflammation and peripheral organ dysfunction are closely linked to disease progression. Notably, the bladder and kidney have emerged as peripheral organs that respond sensitively to neuroinflammation and systemic inflammatory signaling. In this review, we synthesize current evidence supporting a bladder-kidney-brain axis in AD, with emphasis on inflammatory pathways that connect central neurodegeneration with peripheral organ responses. We categorize biomarkers reflecting functional alterations, cellular stress responses, and tissue injury in the bladder and kidney, highlighting mediators reported in both organs. Importantly, many of these biomarkers are measurable in serum and urine, offering accessible peripheral readouts of AD-associated systemic pathology. This integrated framework underscores the biological relevance of urological organs in AD progression and provides a conceptual basis for identifying peripheral signatures associated with early disease-related changes.

Indexed as

Alzheimer diseaseBiomarkersBladder-kidney-brain axisCystitisNephritis

Identifiers

PMID41942332
PMCPMC13053181

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.